205 related articles for article (PubMed ID: 37771589)
1. Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
Leimi L; Koski JR; Kilpivaara O; Vettenranta K; Lokki AI; Meri S
Front Immunol; 2023; 14():1249958. PubMed ID: 37771589
[TBL] [Abstract][Full Text] [Related]
2. Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation.
Leimi L; Jahnukainen K; Olkinuora H; Meri S; Vettenranta K
Bone Marrow Transplant; 2022 May; 57(5):705-711. PubMed ID: 35177827
[TBL] [Abstract][Full Text] [Related]
3. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.
Gavriilaki E; Ho VT; Schwaeble W; Dudler T; Daha M; Fujita T; Jodele S
Exp Hematol Oncol; 2021 Dec; 10(1):57. PubMed ID: 34924021
[TBL] [Abstract][Full Text] [Related]
4. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
5. Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.
Evangelidis P; Evangelidis N; Kalmoukos P; Kourti M; Tragiannidis A; Gavriilaki E
Curr Issues Mol Biol; 2024 May; 46(5):4787-4802. PubMed ID: 38785556
[TBL] [Abstract][Full Text] [Related]
6. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
7. Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.
Ansari M; Petrykey K; Rezgui MA; Del Vecchio V; Cortyl J; Ralph RO; Nava T; Beaulieu P; St-Onge P; Jurkovic Mlakar S; Huezo-Diaz Curtis P; Uppugunduri CRS; Lesne L; Théoret Y; Chalandon Y; Bartelink IH; Boelens JJ; Bredius RGM; Dalle JH; Lewis V; Kangarloo BS; Peters C; Sinnett D; Bittencourt H; Krajinovic M;
Biol Blood Marrow Transplant; 2020 May; 26(5):920-927. PubMed ID: 31790828
[TBL] [Abstract][Full Text] [Related]
8. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study.
Colecchia A; Ravaioli F; Sessa M; Alemanni VL; Dajti E; Marasco G; Vestito A; Zagari RM; Barbato F; Arpinati M; Cavo M; Festi D; Bonifazi F
Biol Blood Marrow Transplant; 2019 May; 25(5):995-1003. PubMed ID: 30660772
[TBL] [Abstract][Full Text] [Related]
9. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease.
Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC
Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238
[TBL] [Abstract][Full Text] [Related]
10. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Gómez-Centurión I; Bailén R; Oarbeascoa G; Muñoz C; Luque AÁ; Boyra ME; Calleja E; Rincón D; Dorado N; Barzallo P; Anguita J; Díez-Martín JL; Kwon M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2089-2097. PubMed ID: 32791193
[TBL] [Abstract][Full Text] [Related]
11. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
12. sVEGF-R1 in acute non-infectious toxicity syndromes after pediatric allogeneic hematopoietic stem cell transplantation.
Horan DE; Kielsen K; Weischendorff SW; Sørum ME; Kammersgaard MB; Ifversen M; Nielsen C; Ryder LP; Johansson PI; Müller K
Transpl Immunol; 2024 Feb; 82():101975. PubMed ID: 38122992
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
[TBL] [Abstract][Full Text] [Related]
14. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
15. Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon Y; Mamez AC; Giannotti F; Beauverd Y; Dantin C; Mahne E; Mappoura M; Bernard F; de Ramon Ortiz C; Stephan C; Morin S; Ansari M; Simonetta F; Masouridi-Levrat S
Transplant Cell Ther; 2022 Nov; 28(11):765.e1-765.e9. PubMed ID: 35953029
[TBL] [Abstract][Full Text] [Related]
16. Grayscale and Spectral Doppler Ultrasound in the Diagnosis of Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Hematopoietic Stem Cell Transplantation in Children.
Kaya N
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1105-e1110. PubMed ID: 34673713
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis.
Eftychidis I; Sakellari I; Anagnostopoulos A; Gavriilaki E
Expert Rev Hematol; 2021 Sep; 14(9):831-840. PubMed ID: 34388057
[TBL] [Abstract][Full Text] [Related]
18. The Prophylaxis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome With Defibrotide After Hematopoietic Stem Cell Transplantation in Children: Single Center Experience.
Karagun BS; Akbas T; Erbey F; Sasmaz İ; Antmen B
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e35-e39. PubMed ID: 34966102
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort.
Dhir A; Wadhwa A; Haines H; Chewning J; Murthy S; Kim J; Beatty L; Mixon E; Fowler KB; Gage J; Meadows T; Goldman F
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e343-e348. PubMed ID: 35200220
[TBL] [Abstract][Full Text] [Related]
20. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
